Methods of detecting autoimmune or immune-related diseases or conditions
This invention provides methods of using phagocytic cells alone or in combination with non-phagocytic cells in the diagnosis, prognosis, or monitoring of autoimmune or immune-related diseases or conditions. The invention also provides methods of using phagocytic cells alone or in combination with non-phagocytic cells to identify markers of autoimmune or immune-related diseases or conditions.
1. An assay for detecting a marker of an autoimmune or immune-related disease or condition in a human subject, wherein the autoimmune or immune-related disease or condition is multiple sclerosis or inflammatory bowel disease, the assay comprising:
a) obtaining a macrophage having a DNA content of more than 2n (>2n macrophage cell) from the blood of the human subject, wherein the >2n macrophage has been separated from phagocytic cells having a DNA content of 2n (=2n phagocytic cells), and detecting a first gene expression profile of the marker of an autoimmune or immune-related disease or condition; and
b) obtaining a non-phagocytic cell from the blood of the human subject and detecting a second gene expression profile of the marker of an autoimmune or immune-related disease or condition in the obtained non-phagocytic cell.
2. The assay of claim 1 , further comprising lysing the >2n macrophage and the non-phagocytic cell before performing the detecting.
3. The assay of claim 1 , further comprising extracting cellular contents from the >2n macrophage and the non-phagocytic cell before performing the detecting.
4. The assay of claim 3 , wherein the cellular contents of the >2n macrophage comprises viable diseased cells, dead diseased cells, apoptotic diseased cells, circulating tumor cells, infectious agents, fetal cells, trophoblasts, or fragments thereof.
5. The assay of claim 1 , wherein the >2n macrophage and the non-phagocytic cell are obtained from a bodily fluid sample, tissues, or cells of the subject.